Raleigh startup raises $17.5M, aims for FDA approval of nasal spray to counter strong allergic reactions
Bryn Pharma, which is developing a nasal spray to counteract life-threatening allergic reactions known as anaphylaxis, says it will move toward securing FDA approval for its product and plan to commercialize it after raising $17.5 million in new financing.
Read More
